Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Kenvue Inc (KVUE)

Kenvue Inc (KVUE)
22.57 x 100 23.33 x 100
Post-market by (Cboe BZX)
23.10 -0.27 (-1.16%) 03/25/25 [NYSE]
22.57 x 100 23.33 x 100
Post-market 23.05 -0.05 (-0.22%) 16:27 ET
Quote Overview for Tue, Mar 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
22.97
Day High
23.49
Open 23.47
Previous Close 23.37 23.37
Volume 14,987,800 14,987,800
Avg Vol 16,702,436 16,702,436
Stochastic %K 33.19% 33.19%
Weighted Alpha +11.12 +11.12
5-Day Change -0.24 (-1.03%) -0.24 (-1.03%)
52-Week Range 17.67 - 24.46 17.67 - 24.46
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,665,704
  • Shares Outstanding, K 1,911,241
  • Annual Sales, $ 15,455 M
  • Annual Income, $ 1,030 M
  • EBIT $ 1,841 M
  • EBITDA $ 2,463 M
  • 60-Month Beta 1.25
  • Price/Sales 2.88
  • Price/Cash Flow 15.84
  • Price/Book 4.62

Options Overview Details

View History
  • Implied Volatility 29.72% ( -10.69%)
  • Historical Volatility 22.71%
  • IV Percentile 66%
  • IV Rank 29.36%
  • IV High 57.53% on 02/05/25
  • IV Low 18.17% on 12/02/24
  • Put/Call Vol Ratio 0.65
  • Today's Volume 3,194
  • Volume Avg (30-Day) 15,120
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 291,748
  • Open Int (30-Day) 233,370

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.23
  • Number of Estimates 6
  • High Estimate 0.24
  • Low Estimate 0.21
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -17.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.72 +1.69%
on 03/14/25
Period Open: 23.37
24.36 -5.17%
on 03/04/25
-0.27 (-1.16%)
since 02/25/25
3-Month
19.75 +16.96%
on 02/06/25
Period Open: 21.56
24.36 -5.17%
on 03/04/25
+1.54 (+7.14%)
since 12/24/24
52-Week
17.67 +30.73%
on 07/11/24
Period Open: 20.65
24.46 -5.56%
on 11/26/24
+2.45 (+11.86%)
since 03/25/24

Most Recent Stories

More News
Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing tariffs...

ITCI : 131.70 (unch)
JNJ : 161.02 (-1.39%)
KVUE : 23.10 (-1.16%)
AMGN : 306.86 (-2.39%)
Kenvue Stock In Focus As TOMS Capital Reportedly Pushes For Sale Or Breakup: Will It Shift Retail Mood?

Earlier this month, the company appointed three new directors, including Starboard Value CEO Jeffrey Smith, to its board as part of an agreement with the activist hedge fund after months of back-and-forth....

JNJ : 161.02 (-1.39%)
KVUE : 23.10 (-1.16%)
IPO : 40.55 (+0.17%)
FPX : 121.22 (+0.22%)
Honeywell Isn't Going to Let a Little Breakup Ruin Its Growth Plans

Investors are usually happy when a company can pull off one big goal and do it well. So Wall Street was almost certainly expecting Honeywell (NASDAQ: HON) to focus all of its attention in the immediate...

HON : 212.12 (+0.13%)
JNJ : 161.02 (-1.39%)
GEHC : 82.46 (+0.93%)
KVUE : 23.10 (-1.16%)
GEV : 336.20 (-2.15%)
GE : 212.13 (+0.90%)
Is Kenvue Stock Outperforming the S&P 500?

Kenvue has outperformed the S&P 500 Index over the past year and analysts remain moderately optimistic about its future outlook.

BDRFY : 25.6900 (-2.65%)
$SPX : 5,776.65 (+0.16%)
KVUE : 23.10 (-1.16%)
2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger

It's time for another Market Cap Game Show. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . To get started investing, check out our beginner's guide to investing...

GOOGL : 170.56 (+1.72%)
ROKU : 81.73 (+0.62%)
AAPL : 223.75 (+1.37%)
DDD : 2.74 (-1.08%)
DDOG : 110.58 (+0.37%)
JNJ : 161.02 (-1.39%)
RXO : 19.11 (+0.42%)
QXO : 13.86 (+0.43%)
UA : 6.08 (-2.09%)
DUOL : 340.50 (+3.18%)
FICO : 1,919.64 (+1.16%)
SBUX : 95.88 (+0.17%)
3 Great Value Stocks That Could Crush the S&P 500 This Year

With the overall market looking expensive, it can be prudent for investors in search of new stocks to add to their portfolios to dig into companies that, for whatever reason, are trading at discounts....

KVUE : 23.10 (-1.16%)
MMM : 153.50 (+0.23%)
DVN : 36.97 (+0.03%)
3 Top High-Yield Dividend Stocks I Just Bought in My Retirement Account

I'm filling my retirement account with dividend stocks. While I like to see the passive income flow into my portfolio, that's not the main factor. The biggest reason is outperformance. Dividend stocks...

INVH : 34.07 (-0.50%)
$SPX : 5,776.65 (+0.16%)
ENB : 44.42 (+0.36%)
KVUE : 23.10 (-1.16%)
Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income

Kenvue (NYSE: KVUE) stock is down since completing its spin-off from Johnson & Johnson (NYSE: JNJ) in August 2023. But with more than a year of results now in the books, investors have had time to acclimate...

JNJ : 161.02 (-1.39%)
KVUE : 23.10 (-1.16%)
J&J Stock Up More Than 6% in a Month: Time to Buy, Sell or Hold?

J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected fourth-quarter earnings report and an optimistic outlook for the Innovative Medicine segment...

ITCI : 131.70 (unch)
JNJ : 161.02 (-1.39%)
KVUE : 23.10 (-1.16%)
AMGN : 306.86 (-2.39%)
Kenvue (KVUE) Q4 2024 Earnings Call Transcript

KVUE earnings call for the period ending December 31, 2024.

KVUE : 23.10 (-1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

See More

Key Turning Points

3rd Resistance Point 23.92
2nd Resistance Point 23.71
1st Resistance Point 23.40
Last Price 23.10
1st Support Level 22.88
2nd Support Level 22.67
3rd Support Level 22.36

See More

52-Week High 24.46
Last Price 23.10
Fibonacci 61.8% 21.87
Fibonacci 50% 21.06
Fibonacci 38.2% 20.26
52-Week Low 17.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals